HBK Sorce Advisory LLC Takes $572,000 Position in BlackRock Health Sciences Trust $BME

HBK Sorce Advisory LLC bought a new position in BlackRock Health Sciences Trust (NYSE:BME) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 13,171 shares of the company’s stock, valued at approximately $572,000.

Several other institutional investors and hedge funds have also made changes to their positions in BME. Sound Income Strategies LLC acquired a new position in BlackRock Health Sciences Trust in the first quarter valued at approximately $36,000. Northwestern Mutual Wealth Management Co. increased its stake in BlackRock Health Sciences Trust by 22.2% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after acquiring an additional 257 shares during the last quarter. Geneos Wealth Management Inc. raised its position in BlackRock Health Sciences Trust by 200.0% in the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after purchasing an additional 3,266 shares during the period. Fifth Third Bancorp purchased a new stake in BlackRock Health Sciences Trust in the first quarter valued at $180,000. Finally, Money Concepts Capital Corp acquired a new position in shares of BlackRock Health Sciences Trust in the 1st quarter valued at $209,000.

BlackRock Health Sciences Trust Stock Up 0.5%

NYSE:BME opened at $44.35 on Tuesday. The company has a 50 day moving average price of $42.58 and a 200 day moving average price of $41.02. BlackRock Health Sciences Trust has a fifty-two week low of $35.95 and a fifty-two week high of $44.99.

BlackRock Health Sciences Trust Dividend Announcement

The firm also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be issued a $0.2621 dividend. This represents a c) annualized dividend and a yield of 7.1%. The ex-dividend date of this dividend is Tuesday, September 15th.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.